Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Explore more
Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...
1d
GlobalData on MSNGoogle-backed Isomorphic Labs raises $600m to advance AI drug discoveryThe funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
It was a bold choice to host a preview screening of The Thinking Game, a documentary about AI company Google DeepMind and its ...
As Google attempts to catch up to OpenAI’s ChatGPT, its DeepMind artificial intelligence unit is in a near constant state of ...
Demis Hassabis was a child chess prodigy, achieving master status in his teens. In a lecture at the University of Cambridge, the Google Deepmind CEO said chess led him to his first experience with AI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results